CIK: 0001538653 · Show all filings
Period: Q4 2021 (← Previous) (Next →)
Filing Date: Feb 14, 2022
Total Value ($000): $2,922,004 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CACC | CREDIT ACCEP CORP MICH | 1,707,005 | $1,173,873 | 40.2% | $107.75 | +497.1% | COM | 225310101 |
| W | WAYFAIR INC | 3,823,239 | $726,301 | 24.9% | $53.95 | +337.5% | CL A | 94419L101 |
| WRLD | WORLD ACCEP CORP DEL | 2,037,495 | $500,062 | 17.1% | $81.92 | +165.4% | COM | 981419104 |
| CMPR | CIMPRESS PLC | 3,906,492 | $279,744 | 9.6% | $129.96 | -37.0% | SHS EURO | G2143T103 |
| YELP | YELP INC | 3,811,985 | $138,146 | 4.7% | $30.67 | +22.5% | CL A | 985817105 |
| GIC | GLOBAL INDUSTRIAL COMPANY | 1,282,421 | $52,451 | 1.8% | $32.63 | +9.1% | COM | 37892E102 |
| — | VAPOTHERM INC | 1,763,739 | $36,527 | 1.3% | $37.84 | — | COM | 922107107 |
| — | 23ANDME HOLDING CO | 1,130,379 | $7,528 | 0.3% | $9.06 | — | CLASS A COM | 90138Q108 |
| LCTX | LINEAGE CELL THERAPEUTICS IN | 1,851,851 | $4,537 | 0.2% | $1.03 | +127.1% | COM | 53566P109 |
| — | LUMIRADX LIMITED | 94,474 | $842 | 0.0% | $8.57 | — | SHS | G5709L109 |
| HUMA | HUMACYTE INC | 80,000 | $580 | 0.0% | $9.89 | 0.0% | COM | 44486Q103 |
| SKIN | THE BEAUTY HEALTH COMPANY | 20,000 | $483 | 0.0% | $21.99 | +17.2% | COM CL A | 88331L108 |
| COUR | COURSERA INC | 17,000 | $415 | 0.0% | $34.67 | -12.3% | COM | 22266M104 |
| SANA | SANA BIOTECHNOLOGY INC | 20,199 | $313 | 0.0% | $19.28 | 0.0% | COM | 799566104 |
| — | AGEX THEREPEUTICS INC | 185,185 | $202 | 0.0% | $2.99 | — | COM | 00848H108 |